Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Andre

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Advances in Experimental Medicine and Biology|August 12, 2003
Exosomes for immunotherapy of cancerNathalie Chaput, N E C Schartz, Fabrice Andre, et al.
Oncoimmunology|April 9, 2016
Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapySylvain Ladoire, David Enot, Fabrice Andre, et al.
Nature Reviews. Clinical Oncology|March 18, 2015
Ki67--no evidence for its use in node-positive breast cancerFabrice Andre, Monica Arnedos, Aicha Goubar, et al.
Cancer Discovery|February 19, 2013
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectivesMaria Vittoria Dieci, Monica Arnedos, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Reply to D.C. Sgroi et al, T. Sanft et al, M.S. Copur et al, and M.P. Goetz et alLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Nature Reviews. Clinical Oncology|March 3, 2011
Implications of personalized medicine--perspective from a cancer centerThomas Tursz, Fabrice Andre, Vladimir Lazar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Reply to A. KatzN Lynn Henry, Fabrice Andre, Nofisat Ismaila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groupsFabrice Andre, Frederique Nowak, Monica Arnedos, et al.
Anticancer Research|September 27, 2015
Predictive and Prognostic Value of the TauProtein in Breast CancerClaire Bonneau, Zachary A Gurard-Levin, Fabrice Andre, et al.
Critical Reviews in Oncology/Hematology|September 12, 2012
Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?Debora Fumagalli, Fabrice Andre, Martine J Piccart-Gebhart, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Advances in Experimental Medicine and Biology|August 12, 2003
Exosomes for immunotherapy of cancerNathalie Chaput, N E C Schartz, Fabrice Andre, et al.
Oncoimmunology|April 9, 2016
Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapySylvain Ladoire, David Enot, Fabrice Andre, et al.
Nature Reviews. Clinical Oncology|March 18, 2015
Ki67--no evidence for its use in node-positive breast cancerFabrice Andre, Monica Arnedos, Aicha Goubar, et al.
Cancer Discovery|February 19, 2013
Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectivesMaria Vittoria Dieci, Monica Arnedos, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2016
Reply to D.C. Sgroi et al, T. Sanft et al, M.S. Copur et al, and M.P. Goetz et alLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
Nature Reviews. Clinical Oncology|March 3, 2011
Implications of personalized medicine--perspective from a cancer centerThomas Tursz, Fabrice Andre, Vladimir Lazar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Reply to A. KatzN Lynn Henry, Fabrice Andre, Nofisat Ismaila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groupsFabrice Andre, Frederique Nowak, Monica Arnedos, et al.
Anticancer Research|September 27, 2015
Predictive and Prognostic Value of the TauProtein in Breast CancerClaire Bonneau, Zachary A Gurard-Levin, Fabrice Andre, et al.
Critical Reviews in Oncology/Hematology|September 12, 2012
Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?Debora Fumagalli, Fabrice Andre, Martine J Piccart-Gebhart, et al.
Pageof 15